We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+17.39%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.66B
AUM Growth
+$537M
Cap. Flow
-$23.3M
Cap. Flow %
-0.5%
Top 10 Hldgs %
6.44%
Holding
1,468
New
106
Increased
604
Reduced
314
Closed
113

Top Buys

Rank Stock Value
1
XRX icon
Xerox
XRX
+$14.1M
2
DAN icon
Dana Inc
DAN
+$12.5M
3
OPEN icon
Opendoor
OPEN
+$10.6M
4
CSCO icon
Cisco
CSCO
+$7.51M
5
JBLU icon
JetBlue
JBLU
+$7.32M

Sector Composition

Rank Sector Weight
1 Financials 26.7%
2 Consumer Discretionary 12.75%
3 Industrials 12.29%
4 Technology 10.9%
5 Healthcare 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGMA
1126
DELISTED
Sigmatron International
SGMA
$212K ﹤0.01%
70,800
ESQ icon
1127
Esquire Financial Holdings
ESQ
$1.14B
$210K ﹤0.01%
+4,204
New +$197K
SALM
1128
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$208K ﹤0.01%
533,845
-135,431
-20% -$85.4K
GURE
1129
Gulf Resources
GURE
$4.85M
$208K ﹤0.01%
12,594
ORIC icon
1130
Oric Pharmaceuticals
ORIC
$1.4B
$207K ﹤0.01%
22,500
-26,200
-54% -$189K
CLSD
1131
DELISTED
Clearside Biomedical
CLSD
$205K ﹤0.01%
11,707
MYO icon
1132
Myomo
MYO
$56.2M
$205K ﹤0.01%
+41,000
New +$109K
CVRX icon
1133
CVRx
CVRX
$63.4M
$204K ﹤0.01%
6,500
-23,800
-79% -$446K
WYY icon
1134
WidePoint Corp
WYY
$114M
$203K ﹤0.01%
87,398
+1,920
+2% +$3.45K
SPRO icon
1135
Spero Therapeutics
SPRO
$73M
$198K ﹤0.01%
134,800
PET
1136
DELISTED
Wag!
PET
$198K ﹤0.01%
111,600
+41,600
+59% +$73.6K
BMTX
1137
DELISTED
BM Technologies, Inc.
BMTX
$197K ﹤0.01%
96,208
+3,072
+3% +$7.95K
RAIL icon
1138
FreightCar America
RAIL
$260M
$197K ﹤0.01%
73,000
CADL icon
1139
Candel Therapeutics
CADL
$776M
$195K ﹤0.01%
132,595
VAXX
1140
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$195K ﹤0.01%
229,100
+154,700
+208% +$149K
VNCE icon
1141
Vince Holding Corp
VNCE
$86.8M
$194K ﹤0.01%
56,186
-16,116
-22% -$23.1K
TBRG
1142
DELISTED
TruBridge
TBRG
$194K ﹤0.01%
+17,303
New +$219K
HYFM icon
1143
Hydrofarm Holdings
HYFM
$7.62M
$194K ﹤0.01%
21,120
+3,620
+21% +$34.9K
EGAN icon
1144
eGain
EGAN
$201M
$193K ﹤0.01%
23,200
FSI icon
1145
Flexible Solutions
FSI
$64.1M
$193K ﹤0.01%
101,007
HYPR icon
1146
Hyperfine
HYPR
$101M
$192K ﹤0.01%
171,600
+7,200
+4% +$10K
LUCD icon
1147
Lucid Diagnostics
LUCD
$184M
$190K ﹤0.01%
135,000
RFIL icon
1148
RF Industries
RFIL
$139M
$188K ﹤0.01%
61,996
VCSA
1149
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$185K ﹤0.01%
22,500
GSIT icon
1150
GSI Technology
GSIT
$258M
$184K ﹤0.01%
69,717

Similar funds

Bridgeway Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Bridgeway Capital Management held 1,468 positions worth $4.66B, up 13% from $4.12B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q4 2023 filing shows 106 new, 604 increased, 314 reduced and 113 closed positions. Its largest new stake was Xerox: 953,092 shares worth $17.5M. The largest sale was Textainer Group Holdings limited, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q4 2023 buy was Xerox: 953,092 shares worth $17.5M.
  • Bridgeway Capital Management added most to Opendoor in Q4 2023, an estimated $10.6M increase.
  • Bridgeway Capital Management's biggest Q4 2023 reduction was Textainer Group Holdings limited, cutting an estimated $19.1M.
  • Bridgeway Capital Management fully exited VERITIV CORPORATION in Q4 2023, selling an estimated $13M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.66B portfolio in Q4 2023.
  • Bridgeway Capital Management opened 106 new positions and closed 113 in Q4 2023.
  • Bridgeway Capital Management's portfolio value rose 13% quarter-over-quarter to $4.66B.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.